These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31517109)

  • 21. Micelle-templated, poly(lactic-
    Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
    Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of polymer blending on the release of ganciclovir from PLGA microspheres.
    Duvvuri S; Gaurav Janoria K; Mitra AK
    Pharm Res; 2006 Jan; 23(1):215-23. PubMed ID: 16320000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
    Wang N; Wu XS
    J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan.
    Fredriksen BN; Sævareid K; McAuley L; Lane ME; Bøgwald J; Dalmo RA
    Vaccine; 2011 Oct; 29(46):8338-49. PubMed ID: 21888940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Regenerative Polymer Blend Composed of Glycylglycine ethyl ester-substituted Polyphosphazene and Poly (lactic-co-glycolic acid).
    Ogueri KS; Ogueri KS; Allcock HR; Laurencin CT
    ACS Appl Polym Mater; 2020 Mar; 2(3):1169-1179. PubMed ID: 32699836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
    Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
    J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 31. Poly (Lactic-Co-Glycolic) Acid-Poly (Vinyl Pyrrolidone) Hybrid Nanoparticles to Improve the Efficiency of Oral Delivery of β-Carotene.
    Liu WY; Hsieh YS; Wu YT
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering.
    Boukari Y; Qutachi O; Scurr DJ; Morris AP; Doughty SW; Billa N
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1966-1983. PubMed ID: 28777694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
    Zhang XQ; Intra J; Salem AK
    J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Evaluation of Multifunctional Poly(Lactic-co-glycolic acid) Nanoparticles Embedded in Carboxymethyl β-Glucan Porous Microcapsules as a Novel Drug Delivery System for Gefitinib.
    Li X; Wang J; Li S; Liu Z; Zheng Z; Zhang Y
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31547272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pro-angiogenic degradable Mg-poly(lactic-co-glycolic acid) implant combined with rhbFGF in a rat limb ischemia model.
    Bao H; Lv F; Liu T
    Acta Biomater; 2017 Dec; 64():279-289. PubMed ID: 28951330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications.
    Zheng X; Wang Y; Lan Z; Lyu Y; Feng G; Zhang Y; Tagusari S; Kislauskis E; Robich MP; McCarthy S; Sellke FW; Laham R; Jiang X; Gu WW; Wu T
    J Biomed Nanotechnol; 2014 Jun; 10(6):900-10. PubMed ID: 24749387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
    Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM
    Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.